Dovitinib in Treating Patients With Recurrent or Progressive Glioblastoma

Update Il y a 5 ans
Reference: NCT01753713

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

This phase II trial studies how well dovitinib works in treating patients with recurrent or progressive glioblastoma. Dovitinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth


Inclusion criteria

  • Adult Giant Cell Glioblastoma,Adult Glioblastoma,Adult Gliosarcoma,Recurrent Adult Brain Tumor

Links